Resolve: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance

Auto-generated challenge from hypothesis h-var-7c976d9fb7 (composite_score=0.812). Target gene: TREM2. Source hypothesis title: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance. Success criteria: 1. TREM2 agonist (AL002 or equivalent) increases perivascular macrophage tau uptake by >40% ex vivo. 2. Tau burden in perivascular regions decreases by >30% vs. vehicle in PS19 tauopathy mice. 3. cerebral spinal fluid (CSF) tau levels decline by >20% after 8 weeks. 4. No increase in inflammatory cytokine release (IL-6, TNF-alpha) vs. baseline.

$500
OPEN
Confidence:
50%
Created: 2026-04-26

Linked Targets (1)

TREM2 Triggering receptor expressed on myeloid cells 2 PDB:5UD70.63
🧬 View 3D Structure — PDB 5UD7 click to expand

Powered by Mol* via PDBe | Rotate: click+drag | Zoom: scroll

Detected Targets:
TREM2TNF

3D Protein Structure

View 3D structure: TREM2 — PDB 6YXY

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll

Landscape analysis not yet run for this challenge. Run the landscape analyzer to get competitive intelligence.

Linked Hypotheses (1)

TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance TREM20.86